Edwards Lifesciences Corp
 
公司簡況
財務
派息紀錄
盈利預測
股權變動
ETF簡況
 
 
 
公司概覽
業務類別 Medical Devices
業務概覽 Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
公司地址 One Edwards Way, Irvine, CA, USA, 92614
電話號碼 +1 949 250-2500
傳真號碼 +1 949 250-2525
公司網頁 https://www.edwards.com
員工數量 16000
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Daniel J. Lippis Corporate Vice President, Transcatheter Aortic Valve Replacemen -- 26/03/2026
Mr. Wayne T. Markowitz General Manager and Senior Vice President, Surgical Structural Heart -- 26/03/2026
Ms. Annette Bruls Corporate Vice President, EMEACLA 美元 726.59K 26/03/2026
Mr. Daveen Chopra Corporate Vice President, Transcatheter Mitral and Tricuspid Therapies 美元 671.04K 26/03/2026
Mr. Bernard J. Zovighian Director and Chief Executive Officer 美元 1.19M 26/03/2026
Mr. Andrew M. Dahl Principal Accounting Officer, Senior Vice President and Corporate Controller -- 25/02/2026
Mr. Donald E. Bobo,Jr Corporate Vice President, Strategy and Corporate Development 美元 759.78K 26/03/2026
Mr. Scott B. Ullem Corporate Vice President and Chief Financial Officer 美元 807.90K 26/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Paul A. Laviolette Independent Director 26/03/2026
Mr. Nicholas J. Valeriani Chairman of the Board 26/03/2026
Ms. Ramona A. Sequeira Independent Director 26/03/2026
Mr. Bernard J. Zovighian Director and Chief Executive Officer 26/03/2026
Mr. Steven R. Loranger Independent Director 26/03/2026
Mr. Kieran T. Gallahue Independent Director 26/03/2026
Ms. Leslie C. Davis Independent Director 26/03/2026
Dr. David T. Feinberg, M.D.,PhD Independent Director 26/03/2026
Ms. Leslie Stone Heisz Independent Director 26/03/2026
 
所屬ETF (更新日期: 02/05/2026 02:15)
代號 名稱 佔比% ▼ 持有日期
JGROJPMorgan Active Growth ETF<0.000001%08/08/2025
LQAILG QRAFT AI-Powrd U.S. Lg Cp Cor ETF<0.000001%24/12/2025
LRNDNYLI U.S. Large Cap R&D Leaders ETF<0.000001%28/08/2025
LSEQHarbor Long-Short Equity ETF<0.000001%28/02/2026
MEDIHarbor Health Care ETF<0.000001%28/04/2026
MMLGFirst Trust Multi-Manager Large Gr ETF<0.000001%06/08/2025
NEWZStockSnips AI-Powered Sen US ALL Cp ETF<0.000001%03/02/2026
NIEVirtus Equity & Convertible Inc Fund<0.000001%30/09/2025
NULGNuveen ESG Large-Cap Growth ETF<0.000001%25/11/2025
PABUiShares Paris-Algnd Clmt Optd MSCIUSAETF<0.000001%04/03/2026
PJFGPGIM Jennison Focused Growth ETF<0.000001%17/04/2026
PRTORCN Pareto Strategic Allocation ETF<0.000001%02/04/2026
PWSPacer WealthShield ETF<0.000001%13/03/2026
QRFTQRAFT AI-Enhanced US Large Cap ETF<0.000001%04/02/2026
RALSProShares RAFI® Long/Short<0.000001%30/04/2022
RNINBushido Capital US SMID Cap Equity ETF<0.000001%22/10/2025
SCHGSchwab US Large-Cap Growth ETF™<0.000001%23/09/2025
SFLRInnovator Equity Managed Floor ETF<0.000001%06/11/2025
SFTYHorizon Managed Risk ETF<0.000001%23/03/2026
SMOTVanEck Morningstar SMID Moat ETF<0.000001%24/03/2026
  1    2    3    4    5    6    7    8    9    10    11    12    13    14    15    16   17    18  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.